Medium-Term Outcomes of Conservative and Surgical Treatments for Stress Urinary Incontinence: A Medicare Claims Analysis: Developed by the AUGS Payment Reform Committee

From the ∗Department of Obstetrics and Gynecology, Tufts University, Boston, MA

†Division of Urogynecology, Department of OBGYN, Vanderbilt University Medical College, Nashville, TN

‡Institute for Informatics, Washington University School of Medicine, St Louis, MO

§Division of Urogynecology and Pelvic Reconstructive Surgery, Department of Obstetrics and Gynecology, Keck School of Medicine at University of Southern California, Los Angeles, CA

∥Division of Urogynecology, Department of OBGYN, University of Texas Medical Branch, Galveston, TX

¶Department of Obstetrics and Gynecology, Denver Health and Hospital Authority, Denver, CO

∗∗Division of Infectious Diseases, Department of Internal Medicine, Washington University in St Louis, St Louis, MO

††KPC Healthcare, UC Riverside School of Medicine, Riverside, CA

‡‡Division of Urogynecology, Subspecialty Care for Women's Health, Cleveland Clinic, Cleveland, OH

§§Department of Obstetrics and Gynecology, Washington University in St Louis, St Louis, MO

Authors are listed in alphabetical order (except for first and senior authors) to recognize their equal contributions to this work.

Correspondence: Evelyn F. Hall, MD. E-mail: [email protected].

Research reported in this presentation was funded by an educational program grant from Boston Scientific to the American Urogynecologic Society. The Center for Administrative Data Research provided statistical support and analysis at Washington University in St Louis. The Center for Administrative Data Research is supported by the Washington University in St Louis Institute of Clinical and Translational Sciences grant UL1 TR002345 from the National Center for Advancing Translational Sciences of the National Institutes of Health. The statements in this presentation are solely the responsibility of the authors.

E.F.H., D.H.B., J.L.B., T.F., G.E.H., T.M.M., K.B.N., and S.L.W. report no conflicts of interest. M.N. reports legal consultation to Ethicon. M.A.O. reports grant funding and consulting fees from Pfizer. J.L.L. serves as an expert witness and reports grant funding from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

This document reflects clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Its content is not intended to be a substitute for professional medical judgment, diagnosis, or treatment. The ultimate judgment regarding any specific procedure or treatment is to be made by the physician and patient in light of all circumstances presented by the patient.

Supplemental digital content is available for this article. Direct URL citations appear in the HTML and PDF versions of this article on the journal’s website (www.urogynecologyjournal.org).

Comments (0)

No login
gif